期刊文献+

腹腔镜手术联合孕三烯酮治疗子宫内膜异位症合并不孕症的临床观察 被引量:5

Clinical observation of laparoscopic surgery combined with gestrinone in the treatment of endometriosis complicated with infertility
下载PDF
导出
摘要 目的观察分析子宫内膜异位症合并不孕症患者在腹腔镜手术后口服孕三烯酮的临床疗效。方法96例行腹腔镜手术治疗的子宫内膜异位症合并不孕症患者作为研究对象,按照数字随机表法分为常规组和研究组,各48例。常规组患者给予单一腹腔镜手术治疗,研究组患者在腹腔镜手术后加用孕三烯酮治疗。对比两组临床治疗效果,治疗前后激素水平,6个月内妊娠率、复发率,不良反应发生情况。结果研究组患者的治疗总有效率为95.83%,明显高于常规组的83.33%,差异具有统计学意义(P<0.05)。治疗前,两组患者的雌二醇与促卵泡激素水平比较差异无统计学意义(P>0.05);治疗后,研究组患者的雌二醇与促卵泡激素水平均显著低于常规组,差异具有统计学意义(P<0.05)。研究组6个月内妊娠率93.75%高于常规组的77.08%,复发率2.08%低于常规组的14.58%,差异具有统计学意义(P<0.05)。研究组患者的不良反应发生率为6.25%,与常规组的8.33%对比,差异无统计学意义(P>0.05)。结论腹腔镜手术治疗子宫内膜异位症合并不孕症患者之后服用孕三烯酮,可进一步改善其激素水平,提高其妊娠率,降低其复发率,临床治疗效果确切、显著,不良反应未增加,值得引起临床重视并大范围借鉴推广。 Objective To observe and analyze the clinical efficacy of oral gestrinone after laparoscopic surgery in the treatment of endometriosis complicated with infertility.Methods A total of 96 cases of endometriosis complicated with infertility undergoing laparopscopic surgery as study subjects were divided into conventional group and research group according to random numerical table,with 48 cases in each group.The conventional group was treated with laparoscopic surgery only,and the research group was treated with laparoscopic surgery combined with gestrinone.The clinical effect,hormone levels before and after treatment,pregnancy rate within 6 months,recurrence rate and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of the research group was 95.83%,which was obviously higher than 83.33%of the conventional group,and the difference was statistically significant(P<0.05).Before treatment,there was no statistically significant difference in estradiol and follicle stimulating hormone between the two groups(P>0.05).After treatment,the estradiol and follicle stimulating hormone level of the research group were significantly lower than those of the conventional group,and the difference was statistically significant(P<0.05).The pregnancy rate within 6 months 93.75%of the research group was higher than 77.08%of the conventional group,and recurrence rate 2.08%was lower than 14.58%of conventional group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions of the research group was 6.25%,which had no statistically significant difference compared with 8.33%of the conventional group(P>0.05).Conclusion Taking gestrinone after laparoscopic surgery in the treatment of endometriosis complicated with infertility can further improve the hormone level,increase the pregnancy rate and reduce the recurrence rate.The clinical treatment effect is exact and significant,and the adverse reactions are not increased.It is worthy of clinical attention and extensive reference and promotion.
作者 李清 LI Qing(Suzhou Xiangcheng People’s Hospital,Suzhou 215131,China)
出处 《中国实用医药》 2021年第16期17-20,共4页 China Practical Medicine
关键词 子宫内膜异位症 不孕症 腹腔镜手术 孕三烯酮 临床疗效 Endometriosis Infertility Laparoscopic surgery Gestrinone Clinical efficacy
  • 相关文献

参考文献11

二级参考文献100

  • 1李华军,冷金花,郎景和,王惠兰,刘珠凤,孙大为,朱兰,丁小曼.子宫内膜异位症保守性手术后复发的相关因素分析[J].中华妇产科杂志,2005,40(1):13-16. 被引量:146
  • 2朱军梅.腹腔镜手术联合GnRH-α治疗子宫内膜异位症合并不孕症的疗效[J].现代实用医学,2007,19(7):572-573. 被引量:6
  • 3子宫内膜异位症的诊断与治疗规范[J].中华妇产科杂志,2007,42(9):645-648. 被引量:563
  • 4Na Young Kim, UiNam Ryoo, Dong - Yun Lee, et al. The efficacy and tolerability of short - term low - dose estrogen - only add - back therapy during post - operative GnRH agonist treatment for endometfi- osis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011,154( 1 ) :85 -89.
  • 5Takehito Imamura, Khaleque N Khan, Akira Fujishita. Effect of Gn- RH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis. Eu- ropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2014,157(9) :16 -23.
  • 6Porpora MG, Pallante D, Ferro A, et al. Pain and ovarian endom- etrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study [ J] . Fertil Steril, 2010, 93 (3) : 716-721.
  • 7Rizkalla HF, Higgins M, Kelehan P, et al. Pathological l]ndings as- sociated with the presence of a mirena intrauterine system at hysterec- tomy [J]. Int J Gynecol Pathol, 2008, 27 (1) : 74-78.
  • 8Riggs MM,Bennetts M,van der Graaf PH, et al. Integrated pharma- cometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometri- osis [ J ]. CPT Pharmacometrics Syst Pharmaco1,20! 2,1 ( 9 ) : el 1.
  • 9Kang JL, Wang XX, Nie ML, et al. Efficacy of gonadotropin-re- leasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis [ J]. Gynecol Obstet Invest, 2010, 69 (2): 73-77.
  • 10Taniguchi F, Higaki H, Azuma Y, et al. Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells [ J ]. Gynecol Obstet Invest, 2013, 75 (1): 9-15.

共引文献200

同被引文献47

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部